EUVIMEDEUVIMED entdecken
Delphi-StudieOpen Access · CC BY 4.0

Occupational exposure risk assessment for cytotoxic drugs among clinical nurses in oncology care settings: development of a Delphi-AHP indicator system

Ran Hao, Mengying Yao, Yuhan Du, Huixin Jin

Frontiers in Oncology · 30.06.2026 · 16

DOI: 10.3389/fonc.2026.1874705 ↗

Kurz gefasst

Delphi-Studie in der Zeitschrift Frontiers in Oncology, online erschienen am 30.06.2026. Verfasst von Ran Hao und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Nursing and Rehabilitation, North China University of Science and Technology, Tangshan, Hebei, China. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To develop a scientific and systematic occupational exposure risk indicator system for cytotoxic drugs (CDs) among clinical nurses and to provide an evidence-based basis for institutional risk management and targeted occupational protection strategies.

Methods

This methodological study used a mixed-methods consensus-building design. Based on the work breakdown structure-risk breakdown structure (WBS-RBS) framework, an initial risk matrix was constructed through literature analysis, policy and guideline review, and semi-structured interviews. Three rounds of Delphi consultation were conducted with 16 experts in oncology nursing, nursing management, pharmacy, and occupational protection/infection control. Indicators were screened using a 5-point Likert scale, and weights were determined using the analytic hierarchy process (AHP).

Results

The response rates for the three Delphi rounds were 80.00%, 93.75%, and 100.00%, respectively. The expert authority coefficients were 0.803, 0.856, and 0.891. In the third round, the coefficient of variation ranged from 0.000 to 0.264, and Kendall’s coefficient of concordance was 0.265 (P<0.01). The final indicator system included five first-level indicators, 13 second-level indicators, and 33 third-level indicators. All AHP judgment matrices met the consistency requirement (CR<0.10).

Conclusion

The indicator system developed in this study integrates full-process clinical work links with multidimensional risk sources, providing a structured and quantifiable framework for early identification, prioritization, and targeted management of occupational exposure risks related to cytotoxic drugs among clinical nurses. It may serve as a practical decision-support reference for developing graded and precise occupational protection strategies, particularly in institutions without centralized intravenous admixture services.

Schlagwörter

Stichwörter der Autor:innen

Delphi methodanalytic hierarchy processclinical nursescytotoxic drugsindicator systemoccupational exposurerisk assessment

Autor:innen und Institutionen

  • College of Nursing and Rehabilitation, North China University of Science and Technology, Tangshan, Hebei, China.
  • Department of Pharmacy, Hebei General Hospital, Shijiazhuang, Hebei, China.
  • Hebei Key Laboratory of Clinical Pharmacy, Shijiazhuang, Hebei, China.
  • The Fifth Department of Neurology, Hebei General Hospital, Shijiazhuang, Hebei, China.

Zitieren

APA

Hao, R., Yao, M., Du, Y., & Jin, H. (2026). Occupational exposure risk assessment for cytotoxic drugs among clinical nurses in oncology care settings: development of a Delphi-AHP indicator system. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1874705

Vancouver

Hao R, Yao M, Du Y, Jin H. Occupational exposure risk assessment for cytotoxic drugs among clinical nurses in oncology care settings: development of a Delphi-AHP indicator system. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1874705

BibTeX
@article{Hao2026,
  author = {Hao, Ran and Yao, Mengying and Du, Yuhan and Jin, Huixin},
  title = {Occupational exposure risk assessment for cytotoxic drugs among clinical nurses in oncology care settings: development of a Delphi-AHP indicator system},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1874705}
}
Kostenlos starten →